| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-745-90 | 62135-745 | HUMAN PRESCRIPTION DRUG | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | TABLET | ORAL | 20230808 | N/A | ANDA | ANDA071881 | Chartwell RX, LLC | VERAPAMIL HYDROCHLORIDE | 120 mg/1 | 90 TABLET in 1 BOTTLE (62135-745-90) |
| 42291-853-01 | 42291-853 | HUMAN PRESCRIPTION DRUG | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | TABLET | ORAL | 20200413 | N/A | ANDA | ANDA071881 | AvKARE | VERAPAMIL HYDROCHLORIDE | 40 mg/1 | 100 TABLET in 1 BOTTLE (42291-853-01) |
| 50090-4013-0 | 50090-4013 | HUMAN PRESCRIPTION DRUG | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | TABLET | ORAL | 20190102 | N/A | ANDA | ANDA071881 | A-S Medication Solutions | VERAPAMIL HYDROCHLORIDE | 120 mg/1 | 100 TABLET in 1 BOTTLE (50090-4013-0) |
| 50090-4013-2 | 50090-4013 | HUMAN PRESCRIPTION DRUG | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | TABLET | ORAL | 20230503 | N/A | ANDA | ANDA071881 | A-S Medication Solutions | VERAPAMIL HYDROCHLORIDE | 120 mg/1 | 30 TABLET in 1 BOTTLE (50090-4013-2) |
| 23155-059-01 | 23155-059 | HUMAN PRESCRIPTION DRUG | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | TABLET | ORAL | 20151015 | N/A | ANDA | ANDA071881 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | VERAPAMIL HYDROCHLORIDE | 40 mg/1 | 100 TABLET in 1 BOTTLE (23155-059-01) |